Pomerantz Law Firm Announces Class Action Lawsuit Against Ardelyx, Inc.
Pomerantz LLP has filed a class action lawsuit against Ardelyx, Inc. (NASDAQ: ARDX) following significant volatility in its stock price. The legal action investigates whether the company and its executives engaged in securities fraud or unlawful business practices regarding financial disclosures. The litigation stems from an August 6, 2026, announcement where Ardelyx reduced its full-year revenue guidance for IBSRELA due to increased payer utilization-management restrictions. Additionally, the company withdrew long-term revenue guidance for XPHOZAH, citing evolving market dynamics and growth uncertainty. Following these disclosures, ARDX shares dropped 17.86% in a single trading session.
Tickers: $ARDX
Topics: Class Action Lawsuit Revenue Guidance Reduction Securities Fraud